Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 5—May 2020

Zika Virus Circulation in Mali

Issa Diarra1, Elif Nurtop1, Abdoul Karim Sangaré, Issaka Sagara, Boris Pastorino, Souleymane Sacko, Amatigué Zeguimé, Drissa Coulibaly, Bakary Fofana, Pierre Gallian, Stephane Priet, Jan Felix Drexler, Anna-Bella Failloux, Abdoulaye Dabo, Mahamadou Ali Thera, Abdoulaye Djimdé, Bourèma Kouriba, Simon Cauchemez, Xavier de LamballerieComments to Author , Nathanaël Hozé, and Ogobara K. Doumbo2
Author affiliations: Unité des Virus Émergents, (UVE: Aix-Marseille Univ-IRD 190-INSERM 1207-IHU Méditerranée Infection), Marseille, France (I. Diarra, E. Nurtop, B. Pastorino, P. Gallian, S. Priet, X. de Lamballerie); Malaria Research and Training Center—Université des Sciences, des Techniques et des Technologies de Bamako, Mali (I. Diarra, A.K. Sangaré, I. Sagara, A. Zeguimé, D. Coulibaly, B. Fofana, A. Dabo, M.A. Thera, A. Djimdé, B. Kouriba, O.K. Doumbo); Centre d’Infectiologie Charles Mérieux, Bamako (A.K. Sangaré, B. Kouriba); Ministère de la Santé et des Affaires Sociales du Mali, Bamako (S. Sacko); Laboratoire de Virologie, Établissement Français du Sang Provence-Alpes Côte-d'Azur et Corse (EFS), Marseille (P. Gallian); German Center for Infection Research, Bonn-Cologne, Germany (J.F. Drexler); Charité-Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany (J.F. Drexler); Institut Pasteur, Paris, France (A.-B. Failloux, S. Cauchemez, N. Hozé); Centre National de la Recherche Scientifique, Paris (S. Cauchemez, N. Hozé)

Main Article

Table 3

Results of seroepidemiological investigations for Zika virus according to study sites and time of sampling, Mali

Study site and year Total no. IgG* doubtful, no. (%) IgG* positive, no. (%) VNT† positive, no. (%)
Niono 2016 65 4 (6 0.2) 4 (6.2) 2 (3.1)
Bamako 2016 129 0 (0.0) 11 (8.5) 7 (5.4)
Bamako 2013‡ 637 18 (2.8) 67 (10.5) 47 (7.4)
Kadiolo 2016 136 14 (10.3) 22 (16.2) 14 (10.3)
Bougouni 2016 127 3 (2.4) 22 (17.3) 15 (11.8)
Kita 2016 40 5 (12.5) 7 (17.5) 6 (15.0)
Bandiagara 2016 187 24 (12.8) 81 (43.3) 29 (15.5)
Diéma 2016
14 (12.8)
39 (35.8)
22 (20.2)
Total 1,430 82 (5.7) 253 (17.7) 142 (9.9)

*Result by Euroimmun IgG ELISA assay.
†Result by cytopathic effect-based virus neutralization test.
‡Volunteer blood donors.

Main Article

1These authors contributed equally to this article.


Page created: April 16, 2020
Page updated: April 16, 2020
Page reviewed: April 16, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.